Solvay Third Quarter 2025 Results
| | Third quarter | Nine months | ||||||
| Underlying (in € million) | 2025 | 2024 | % yoy | % organic | 2025 | 2024 | % yoy | % organic |
| Net sales | 1,044 | 1,156 | -9.7% | -6.8% | 3,267 | 3,552 | -8.0% | -5.5% |
| EBITDA | 232 | 259 | -10.3% | -6.9% | 712 | 796 | -10.6% | -8.4% |
| EBITDA margin | 22.2% | 22.4% | -0.1pp | | 21.8% | 22.4% | | |
| FCF 1 | 117 | 74 | +57.9% | | 214 | 320 | -33.2% | |
| ROCE | | | | | 15.4% | 17.3% | |
1 Free Cash Flow (FCF) here is the free cash to Solvay shareholders from continuing operations.
Philippe Kehren, Solvay CEO
“In Q3, our Basic Chemicals business had a stable level of activity compared to the previous quarter, except in soda ash in Southeast Asia. Our Performance Chemicals business was down sequentially, mainly due to the usual seasonality in Silica and the non-repeat gains of Special Chem in Q2, while Coatis remained stable at a low level. Looking at what we achieved in the first nine months, and how the organization is focusing on our priorities, I'm confident we will deliver our 2025 objectives.
Looking at the longer term, we are taking tailored actions across our portfolio of businesses: we prepare the future by making disciplined investments in areas where demand is strong, including electronic grade peroxide, circular silica and rare earths, and by adjusting our footprint as necessary; and we continue to work on the transformation of the company, and making sure we deliver on our structural cost savings commitment.”
2025 outlook
Given Solvay financial performance in the first nine months of the year, despite the challenging market environment and continued forex headwinds, Solvay confirms its 2025 guidance, as follows:
- Underlying EBITDA to be between €880 million and €930 million. Free Cash Flow from continuing operations to Solvay shareholders to be around €300 million, with a maximum of €300 million of Capex, reflecting management's focus on cash generation and dividend cover. Cumulated cost savings to exceed €200 million at the end of 2025.
Financial calendar
- Link to Solvay's financial calendar
Details of analysts and investors conference call
- Time: November 6, 2025 - 2pm CET Registration: register to the webcast here.
Contacts
Investor relations
Geoffroy d'Oultremont: +32 478 88 32 96
Vincent Toussaint: +33 6 74 87 85 65
Charlotte Vandevenne: +32 471 68 01 66
...
Media relations
Peter Boelaert: +32 479 30 91 59
Laetitia Van Minnenbruggen: +32 484 65 30 47
...
About Solvay
Solvay, a pioneering chemical company with a legacy rooted in founder Ernest Solvay's pivotal innovations in the soda ash process, is dedicated to delivering essential solutions globally through its workforce of around 9,000 employees. Since 1863, Solvay has harnessed the power of chemistry to create innovative, sustainable solutions that answer the world's most essential needs such as purifying the air we breathe and the water we use, preserving our food supplies, protecting our health and well-being, creating eco-friendly clothing, making the tires of our cars more sustainable and cleaning and protecting our homes. Solvay's unwavering commitment drives the transition to a carbon-neutral future by 2050, underscoring its dedication to sustainability and a fair and just transition. As a world-leading company with €4.7 billion in underlying net sales in 2024, Solvay is listed on Euronext Brussels and Paris (SOLB). For more information about Solvay, please visit or follow Solvay on Linkedin.
Safe harbor
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
Ce communiqué de presse est également disponible en français.
Dit persbericht is ook in het Nederlands beschikbaar.
Attachments
-
Financial report
Press release
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment